Following the approval of its managed wind down in February 2025, Schroder Capital Global Innovation is ready to start handing back some money to shareholders. With the cash that the trust already had, the realisation of Araris Biotech in April and an anticipated partial realisation of the company’s interests in AI Company II, there is … Continue reading Schroder Capital Global Innovation launches tender offer